CB2 receptor agonists (Institute Cajal)

N/A

Report date: 2025/01/26 19:18:03
NME

Base Information

Drug NameCB2 receptor agonists (Institute Cajal)
Drug Alias NamePM-226
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsCentral Nervous System Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCajal Institute
China Registration ClassN/A

Develop Information

Active CompaniesCajal Institute
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A